Annual CFF
$163.54 M
-$22.00 K-0.01%
December 31, 2023
Summary
- As of February 8, 2025, COGT annual cash flow from financing activities is $163.54 million, with the most recent change of -$22.00 thousand (-0.01%) on December 31, 2023.
- During the last 3 years, COGT annual CFF has fallen by -$68.66 million (-29.57%).
- COGT annual CFF is now -29.57% below its all-time high of $232.20 million, reached on December 31, 2020.
Performance
COGT Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$624.00 K
+$880.00 K+343.75%
September 30, 2024
Summary
- As of February 8, 2025, COGT quarterly cash flow from financing activities is $624.00 thousand, with the most recent change of +$880.00 thousand (+343.75%) on September 30, 2024.
- Over the past year, COGT quarterly CFF has increased by +$880.00 thousand (+343.75%).
- COGT quarterly CFF is now -99.71% below its all-time high of $214.06 million, reached on March 31, 2024.
Performance
COGT Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$214.43 M
-$376.00 K-0.18%
September 30, 2024
Summary
- As of February 8, 2025, COGT TTM cash flow from financing activities is $214.43 million, with the most recent change of -$376.00 thousand (-0.18%) on September 30, 2024.
- Over the past year, COGT TTM CFF has dropped by -$376.00 thousand (-0.18%).
- COGT TTM CFF is now -43.15% below its all-time high of $377.15 million, reached on March 31, 2024.
Performance
COGT TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
COGT Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.0% | +343.8% | -0.2% |
| 3 y3 years | -29.6% | +1034.5% | +75.6% |
| 5 y5 years | +132.5% | +906.5% | +10000.0% |
COGT Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.0% | +330.6% | -99.7% | +343.8% | -43.1% | +464.6% |
| 5 y | 5-year | -29.6% | >+9999.0% | -99.7% | +343.8% | -43.1% | >+9999.0% |
| alltime | all time | -29.6% | >+9999.0% | -99.7% | +185.0% | -43.1% | >+9999.0% |
Cogent Biosciences Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $624.00 K(-343.8%) | $214.43 M(-0.2%) |
| Jun 2024 | - | -$256.00 K(-100.1%) | $214.80 M(-43.0%) |
| Mar 2024 | - | $214.06 M(>+9900.0%) | $377.15 M(+130.6%) |
| Dec 2023 | $163.54 M(-0.0%) | $0.00(-100.0%) | $163.54 M(-0.2%) |
| Sep 2023 | - | $1.00 M(-99.4%) | $163.85 M(+0.0%) |
| Jun 2023 | - | $162.09 M(>+9900.0%) | $163.84 M(-0.0%) |
| Mar 2023 | - | $445.00 K(+41.3%) | $163.87 M(+0.2%) |
| Dec 2022 | $163.56 M(+330.7%) | $315.00 K(-68.2%) | $163.56 M(-18.7%) |
| Sep 2022 | - | $990.00 K(-99.4%) | $201.25 M(+0.5%) |
| Jun 2022 | - | $162.12 M(>+9900.0%) | $200.31 M(+424.4%) |
| Mar 2022 | - | $138.00 K(-99.6%) | $38.20 M(+0.6%) |
| Dec 2021 | $37.98 M(-83.6%) | $38.01 M(>+9900.0%) | $37.98 M(-68.9%) |
| Sep 2021 | - | $55.00 K(>+9900.0%) | $122.11 M(-47.4%) |
| Jun 2021 | - | $0.00(-100.0%) | $231.98 M(-0.0%) |
| Mar 2021 | - | -$85.00 K(-100.1%) | $232.04 M(-0.1%) |
| Dec 2020 | $232.20 M | $122.14 M(+11.1%) | $232.20 M(+111.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $109.92 M(>+9900.0%) | $110.06 M(>+9900.0%) |
| Jun 2020 | - | $62.00 K(-15.1%) | $135.00 K(-20.6%) |
| Mar 2020 | - | $73.00 K(>+9900.0%) | $170.00 K(+57.4%) |
| Dec 2019 | $108.00 K(-99.8%) | $0.00(0.0%) | $108.00 K(-78.5%) |
| Sep 2019 | - | $0.00(-100.0%) | $503.00 K(-25.8%) |
| Jun 2019 | - | $97.00 K(+781.8%) | $678.00 K(-99.0%) |
| Mar 2019 | - | $11.00 K(-97.2%) | $70.89 M(+0.8%) |
| Dec 2018 | $70.35 M(-9749.7%) | $395.00 K(+125.7%) | $70.35 M(+1.6%) |
| Sep 2018 | - | $175.00 K(-99.8%) | $69.22 M(+0.2%) |
| Jun 2018 | - | $70.31 M(<-9900.0%) | $69.05 M(-5562.6%) |
| Mar 2018 | - | -$535.00 K(-27.1%) | -$1.26 M(+73.4%) |
| Dec 2017 | -$729.00 K(+1722.5%) | -$734.00 K(<-9900.0%) | -$729.00 K(<-9900.0%) |
| Sep 2017 | - | $5000.00(>+9900.0%) | $5000.00(>+9900.0%) |
| Jun 2017 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2017 | - | $0.00 | $0.00 |
| Dec 2016 | -$40.00 K(-100.1%) | - | - |
| Dec 2015 | $70.75 M | - | - |
FAQ
- What is Cogent Biosciences annual cash flow from financing activities?
- What is the all time high annual CFF for Cogent Biosciences?
- What is Cogent Biosciences annual CFF year-on-year change?
- What is Cogent Biosciences quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Cogent Biosciences?
- What is Cogent Biosciences quarterly CFF year-on-year change?
- What is Cogent Biosciences TTM cash flow from financing activities?
- What is the all time high TTM CFF for Cogent Biosciences?
- What is Cogent Biosciences TTM CFF year-on-year change?
What is Cogent Biosciences annual cash flow from financing activities?
The current annual CFF of COGT is $163.54 M
What is the all time high annual CFF for Cogent Biosciences?
Cogent Biosciences all-time high annual cash flow from financing activities is $232.20 M
What is Cogent Biosciences annual CFF year-on-year change?
Over the past year, COGT annual cash flow from financing activities has changed by -$22.00 K (-0.01%)
What is Cogent Biosciences quarterly cash flow from financing activities?
The current quarterly CFF of COGT is $624.00 K
What is the all time high quarterly CFF for Cogent Biosciences?
Cogent Biosciences all-time high quarterly cash flow from financing activities is $214.06 M
What is Cogent Biosciences quarterly CFF year-on-year change?
Over the past year, COGT quarterly cash flow from financing activities has changed by +$880.00 K (+343.75%)
What is Cogent Biosciences TTM cash flow from financing activities?
The current TTM CFF of COGT is $214.43 M
What is the all time high TTM CFF for Cogent Biosciences?
Cogent Biosciences all-time high TTM cash flow from financing activities is $377.15 M
What is Cogent Biosciences TTM CFF year-on-year change?
Over the past year, COGT TTM cash flow from financing activities has changed by -$376.00 K (-0.18%)